US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.41 against a street estimate of 0.33 — a beat of 24.2%.
Analysts rate Envista Holdings Corp a buy (8 buy, 7 hold, 0 sell out of 15) with an average price target of $29.54.
CONFIDENT Envista delivered 5% core growth in Q2 with 28% EBITDA growth and 58% EPS growth. Raised full-year guidance across all metrics. Equipment & Consumables accelerating; VBP implementation expected in China second half. Q2 2026 All major geographies posted growth in Q2. China down year-to-date due to VBP compression; expected to grow moderately in second half post-VBP implementation. Analysts pressed heavily on China VBP timing, underlying growth rates, and margin drivers. Management reiterated VBP as net positive long-term based on implants VBP 1 precedent. Addressed concerns that H2 deceleration was conservative; confirmed 3.5% normalized ex adjustments. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 11.48% |
| Ariel Investments, LLC | 6.11% |
| Dimensional Fund Advisors, Inc. | 5.96% |
| Vanguard Portfolio Management, LLC | 4.66% |
| Vanguard Capital Management, LLC | 4.57% |
| Morgan Stanley - Brokerage Accounts | 4.01% |
| Gates Capital Management Inc | 3.46% |
| State Street Corp | 3.32% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 ENVISTA HOLDINGS CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: September 17, 2026 • Company: Envista Holdings Corporation • Ticker | 2026-09-17 |
| Board / officer change · Q3 2026 ENVISTA HOLDINGS CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Paul Keel (President and CEO) base salary increased by $200,000: from $1.1 millio | 2026-08-19 |
| Quarterly report · Q3 2026 ENVISTA HOLDINGS CORPORATION – FORM 10-Q SUMMARY For Quarterly Period Ended July 3, 2026 --- HEADLINE NUMBERS • Sales (6 months): $1,436.0 million, | 2026-08-05 |
| Results announced · Q3 2026 ENVISTA HOLDINGS CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Sales: $730.5 million, up 7.1% vs. Q2 2025 ($682.1 million) • Cor | 2026-08-05 |
| Board / officer change · Q2 2026 ENVISTA HOLDINGS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics or performance data disclosed in this filing • Document is a | 2026-06-03 |
| Shareholder vote results · Q2 2026 ENVISTA HOLDINGS CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held on May 19, 2026 • Total votes cast for director el | 2026-05-21 |
| Quarterly report · Q2 2026 ENVISTA HOLDINGS CORPORATION – Q1 2026 (10-Q) SUMMARY HEADLINE NUMBERS • Sales: $705.5 million (Q1 2026) vs. $616.9 million (Q1 2025) — +14.3% growt | 2026-05-06 |
| Proxy statement · Q4 2025 ENVISTA HOLDINGS CORPORATION – 2026 PROXY SUMMARY --- CEO COMPENSATION • Paul Keel (President and CEO since 2024) compensation figures not fully de | 2026-04-07 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Envista Holdings Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.